HLA-DRB4 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. The presence of DRB4 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.
Target
HLA Class II Histocompatibility Antigen, DR Beta 4 Chain (HLA-DRB4)
Clonality
Polyclonal
Reactivity
Human
Tested Applications
ELISA, WB
Host
Rabbit
Recommended dilutions
WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Immunogen
KLH-conjugated synthetic peptide between 43-72 amino acids from the N-terminal region of human HLA-DRB4.
Isotype
IgG
Form
Liquid
Purification
Purified through a protein A column, followed by peptide affinity purification.
Storage
Aliquot and store at 2-8°C for up to 2 weeks, or at -20°C for long term storage. Avoid repeated freeze/thaw cycles.
We use cookies necessary for the function of our website, to improve your experience, analyse our traffic, and cookies that optimise the performance. To learn more about our cookies, please read our Cookie Notice.